Advantek has adopted a practical, prudent and achievable business model with an aim to minimize risk exposure and to maximize returns to shareholders. Leveraging on its competitive advantages in technology know-how and geographical location, Advantek has teamed up with the following organizations as our licensors or technical partners.

Amersham Biosciences Inc, Sweden
Chinese University of Hong Kong, Hong Kong
Enzyme Research Laboratories, US
Gradipore Limited, Australia
Hong Kong Institute of Biotechnology, Hong Kong
New York Blood Center, US
School of Public Health of Sun Yat-Sen University, China
Prince of Wales Hospital, Hong Kong
Guangzhou Jinan Biomedical Research & Development Center, China